Alta Wealth Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Alta Wealth Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,265	Closed	-$1.35M	–	138
2023 Q2	$1.35M	Hold	34,265	–	–	0.79%	33
2023 Q1	$834K	Hold	34,265	–	–	0.53%	61
2022 Q4	$734K	Hold	34,265	–	–	0.5%	64
2022 Q3	$615K	Hold	34,265	–	–	0.44%	68
2022 Q2	$329K	Hold	34,265	–	–	0.23%	113
2022 Q1	$577K	Buy	34,265 +20,000	+140%	+$296K	0.34%	93
2021 Q4	$239K	Sell	14,265 -17,432	-55%	-$286K	0.15%	135
2021 Q3	$515K	Hold	31,697	–	–	0.37%	93
2021 Q2	$200K	Hold	31,697	–	–	0.15%	141
2021 Q1	$196K	Hold	31,697	–	–	0.16%	129
2020 Q4	$219K	Buy	+31,697	New	+$203K	0.18%	131

Alta Wealth Advisors's ISEE Position: Q3 2023 in Review

Alta Wealth Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 34,265 shares — an estimated $1.35M sold.

Alta Wealth Advisors first reported a position in ISEE in Q4 2020 and held it in 11 quarters. The position peaked at $1.35M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Alta Wealth Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alta Wealth Advisors sold 34,265 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.35M.
Alta Wealth Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Alta Wealth Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.35M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Alta Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.